ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) is a Healthcare company (Drug Manufacturers - Specialty & Generic) with a market capitalization of $1.6B. The Maz Rating grades it against the other companies in its sector.
ANI Pharmaceuticals, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $69.99, ANI Pharmaceuticals, Inc. trades at 13.5x trailing earnings, 1.5x sales and 2.3x book value, with an EV/EBITDA of 5.4. Over the last twelve months it generated about $1.0B of revenue and $118M of net income. It runs a gross margin of 67.8%, an operating margin of 17.3% and a net margin of 11.2%. It shows return on equity of 20.0%, return on invested capital of 10.5% and a free cash flow yield of 11.1%. On the balance sheet: a debt-to-equity ratio of 0.47 and a current ratio of 2.75. Over the past 52 weeks the share price ranged from $67.14 to $87.76, with a beta of 0.47.
ANI Pharmaceuticals, Inc. does not currently pay a dividend.
10 Wall Street analyst ratings cover the stock: 6 Buy and 4 Hold, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.